Xu Ming, Li Xiao-Xue, Wang Lei, Wang Mi, Zhang Yang, Li Pin-Lan
Department of Pharmacology and Toxicology, School of Medicine, Virginia Commonwealth University, Richmond, Virginia, USA.
Cell Physiol Biochem. 2015;37(2):432-44. doi: 10.1159/000430366. Epub 2015 Aug 28.
BACKGROUND/AIMS: Recent studies have indicated that CD38 gene deficiency results in dedifferentiation or transdifferentiation of arterial smooth muscle cells upon atherogenic stimulations. However, the molecular mechanisms mediating this vascular smooth muscle (SMC) phenotypic switching remain unknown. Methods &
In the present study, we first characterized the phenotypic change in the primary cultures of coronary arterial myocytes (CAMs) from CD38-/- mice. It was shown that CD38 deficiency decreased the expression of contractile marker calponin, SM22α and α-SMA but increased the expression of SMC dedifferentiation marker, vimentin, which was accompanied by enhanced cell proliferation. This phenotypic change in CD38-/- CAMs was enhanced by 7-ketocholesterol (7-Ket), an atherogenic stimulus. We further found that the CD38 deficiency decreased the expression and activity of nuclear factor E2-related factor 2 (Nrf2), a basic leucine zipper (bZIP) transcription factor sensitive to redox regulation. Similar to CD38 deletion, Nrf2 gene silencing increased CAM dedifferentiation upon 7-Ket stimulation. In contrast, the overexpression of Nrf2 gene abolished 7-Ket-induced dedifferentiation in CD38-/- CAMs. Given the sensitivity of Nrf2 to oxidative stress, we determined the role of redox signaling in the regulation of Nrf2 expression and activity associated with CD38 effect in CAM phenotype changes. It was demonstrated that in CD38-/- CAMs, 7-Ket failed to stimulate the production of O2-., while in CD38+/+ CAMs 7-Ket induced marked O2-. production and enhancement of Nrf2 activity, which was substantially attenuated by NOX4 gene silencing. Finally, we demonstrated that 7-Ket-induced and NOX4-dependent O2-. production was inhibited by 8-Br-cADPR, an antagonist of cADPR or NED-19, an antagonist of NAADP as product of CD38 ADP-ribosylcyclase, which significantly inhibited the level of cytosolic Ca2+ and the activation of Nrf2 under 7-Ket.
Taken together, these results suggest that CD38 activity is required for 7-Ket-induced Ca2+ and consequently O2-. production in CAMs, which increases Nrf2 activity to maintain their differentiated status. When CD38 gene expression and function are deficient, the Nrf2 activity is suppressed, thereby leading to phenotypic switching of CAMs.
背景/目的:最近的研究表明,CD38基因缺陷会导致动脉平滑肌细胞在致动脉粥样硬化刺激下发生去分化或转分化。然而,介导这种血管平滑肌(SMC)表型转换的分子机制仍不清楚。方法与结果:在本研究中,我们首先对来自CD38基因敲除小鼠的冠状动脉心肌细胞(CAMs)原代培养物中的表型变化进行了表征。结果显示,CD38缺陷降低了收缩标记物钙调蛋白、SM22α和α-SMA的表达,但增加了SMC去分化标记物波形蛋白的表达,同时伴有细胞增殖增强。致动脉粥样硬化刺激物7-酮胆固醇(�-Ket)增强了CD38基因敲除的CAMs中的这种表型变化。我们进一步发现,CD38缺陷降低了核因子E2相关因子2(Nrf2)的表达和活性,Nrf2是一种对氧化还原调节敏感的碱性亮氨酸拉链(bZIP)转录因子。与CD38基因缺失类似,Nrf2基因沉默增强了7-酮胆固醇刺激下的CAM去分化。相反,Nrf2基因的过表达消除了7-酮胆固醇诱导的CD38基因敲除的CAMs中的去分化。鉴于Nrf2对氧化应激的敏感性,我们确定了氧化还原信号在调节与CD38在CAM表型变化中的作用相关的Nrf2表达和活性中的作用。结果表明,在CD38基因敲除的CAMs中,7-酮胆固醇未能刺激超氧阴离子(O₂⁻)的产生,而在CD38基因野生型的CAMs中,7-酮胆固醇诱导了显著的O₂⁻产生和Nrf2活性增强,NOX4基因沉默可显著减弱这种增强。最后,我们证明,7-酮胆固醇诱导的和NOX4依赖性的O₂⁻产生受到8-溴环磷腺苷(8-Br-cADPR)(一种环磷腺苷(cADPR)拮抗剂)或NED-19(一种烟酰胺腺嘌呤二核苷酸磷酸(NAADP)拮抗剂,CD38 ADP-核糖基环化酶的产物)的抑制,这两种拮抗剂在7-酮胆固醇作用下显著抑制了胞质Ca²⁺水平和Nrf2的激活。结论:综上所述,这些结果表明,CD38活性是7-酮胆固醇诱导的Ca²⁺以及因此在CAMs中产生O₂⁻所必需的,这会增加Nrf2活性以维持其分化状态。当CD38基因表达和功能缺陷时,Nrf2活性受到抑制,从而导致CAMs的表型转换。